» Articles » PMID: 36606460

Responses of Retinal and Brain Microvasculature to Streptozotocin Induced Diabetes Revealed by Global Expression Profiling

Overview
Publisher Sage Publications
Date 2023 Jan 6
PMID 36606460
Authors
Affiliations
Soon will be listed here.
Abstract

This study aims to determine the effects of diabetes in the retinal and brain microvasculature through gene expression profiling. Twelve male Wistar rats were randomly divided into two groups: streptozotocin-induced diabetic rats and time-matched nondiabetic rats. The retinal microvessels (RMVs) and brain microvessels (BMVs) were mechanically isolated from individual rats. Differentially expressed genes (DEGs) in diabetic and nondiabetic microvessels were identified by cDNA microarrays analysis. In RMVs, we identified 43 DEGs, of which 20 were upregulated while 23 were downregulated by diabetes. In BMVs, 35 genes DEGs were identified, of which 22 were upregulated and 13 were downregulated by diabetes. Altered expression of the Nars, Gars, Mars, Iars, Yars, Bcl2, Nqo1, NR4A3, Gpd1, Stc1, Tsc22d3, Tnfrsf21 mRNA as observed in the microarray analyses, was confirmed by quantitative RT-PCR. The aminoacyl-tRNA synthetases (aaRSs) pathway in RMVs was significantly overrepresented as compared to BMVs. Our study demonstrates for the first time that in the brain microvasculature multiple compensatory mechanisms exists, serving to protect brain tissue from diabetic insults, whereas these mechanisms are not activated in the retinal microvasculature. This provides new insights as to why brain microvasculature is less susceptible to diabetes.

Citing Articles

Global genomic profile of hippocampal endothelial cells by single-nuclei RNA sequencing in female diabetic mice is associated with cognitive dysfunction.

Milenkovic D, Nuthikattu S, Norman J, Villablanca A Am J Physiol Heart Circ Physiol. 2024; 327(4):H908-H926.

PMID: 39150395 PMC: 11901383. DOI: 10.1152/ajpheart.00251.2024.


Low-Dose Trans-Resveratrol Ameliorates Diabetes-Induced Retinal Ganglion Cell Degeneration via TyrRS/c-Jun Pathway.

Xiao K, Ma X, Zhong Z, Zhao Y, Chen X, Sun X Invest Ophthalmol Vis Sci. 2023; 64(7):2.

PMID: 37261387 PMC: 10241309. DOI: 10.1167/iovs.64.7.2.

References
1.
Pan J, Huang L, Belousova T, Lu L, Yang Y, Reddel R . Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathway. J Am Soc Nephrol. 2014; 26(2):364-78. PMC: 4310644. DOI: 10.1681/ASN.2013070703. View

2.
Liu D, Huang L, Wang Y, Wang W, Wehrens X, Belousova T . Human stanniocalcin-1 suppresses angiotensin II-induced superoxide generation in cardiomyocytes through UCP3-mediated anti-oxidant pathway. PLoS One. 2012; 7(5):e36994. PMC: 3365029. DOI: 10.1371/journal.pone.0036994. View

3.
Kandpal R, Rajasimha H, Brooks M, Nellissery J, Wan J, Qian J . Transcriptome analysis using next generation sequencing reveals molecular signatures of diabetic retinopathy and efficacy of candidate drugs. Mol Vis. 2012; 18:1123-46. PMC: 3351417. View

4.
Jiang T, Huang Z, Lin Y, Zhang Z, Fang D, Zhang D . The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes. 2010; 59(4):850-60. PMC: 2844833. DOI: 10.2337/db09-1342. View

5.
Joussen A, Huang S, Poulaki V, Camphausen K, Beecken W, Kirchhof B . In vivo retinal gene expression in early diabetes. Invest Ophthalmol Vis Sci. 2001; 42(12):3047-57. View